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Abstract Bacteriophages (phages), natural enemies of bacte-
ria, can encode enzymes able to degrade polymeric sub-
stances. These substances can be found in the bacterial cell
surface, such as polysaccharides, or are produced by bacteria
when they are living in biofilm communities, the most com-
mon bacterial lifestyle. Consequently, phages with
depolymerase activity have a facilitated access to the host
receptors, by degrading the capsular polysaccharides, and
are believed to have a better performance against bacterial
biofilms, since the degradation of extracellular polymeric sub-
stances by depolymerases might facilitate the access of phages
to the cells within different biofilm layers. Since the diversity
of phage depolymerases is not yet fully explored, this is the
first review gathering information about all the depolymerases
encoded by fully sequenced phages. Overall, in this study, 160
putative depolymerases, including sialidases, levanases,
xylosidases, dextranases, hyaluronidases, peptidases as well
as pectate/pectin lyases, were found in 143 phages (43
Myoviridae, 47 Siphoviridae, 37 Podoviridae, and 16 unclas-
sified) infecting 24 genera of bacteria. We further provide
information about the main applications of phage
depolymerases, which can comprise areas as diverse as med-
ical, chemical, or food-processing industry.
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Introduction
Phages are natural bacterial viruses and constitute the most
abundant entities on Earth (Clokie et al. 2011). Phages have
been used in clinical practice since the early 1920s (Kutter et
al. 2010; Abedon et al. 2011), and although there was a period
of declining interest on phage therapy after the antibiotics
discovery (Kutter et al. 2010), the interest on phages re-
emerged with the rise of antibiotic-resistant bacteria
(Sulakvelidze 2005; Matsuzaki et al. 2005; Kutateladze and
Adamia 2010). Therefore, many studies have reported the
potential of phages as antimicrobial agents (McVay et al.
2007; Capparelli et al. 2007; Guenther et al. 2009; Oliveira
et al. 2010; Morello et al. 2011; Trigo et al. 2013; Bertozzi
Silva and Sauvageau 2014). However, the activity of phages is
often hindered by the presence of polysaccharides at the bac-
terial surfaces and/or when bacteria are living in the biofilm
form.
Biofilms are defined as microbial communities attached to
a surface and encased in a matrix composed by extracellular
polymeric substances (EPS) (Costerton et al. 1995; O’Toole et
al. 2000), which represent over 90 % of the biofilm biomass
(Flemming and Wingender 2010). The EPS matrix is consti-
tuted by a mixture of polysaccharides, proteins, nucleic acids,
and lipids (Davey and O’toole 2000; Flemming et al. 2007;
Flemming and Wingender 2010), and its composition varies
with bacterial species, age of the biofilms, and environmental
conditions such as temperature or nutrients availability
(Flemming et al. 2007; Vu et al. 2009; Flemming and
Wingender 2010; Harper et al. 2014). Biofilms are ubiquitous
in nature (Davey and O’toole 2000; Donlan 2002), and on
Electronic supplementary material The online version of this article
(doi:10.1007/s00253-015-7247-0) contains supplementary material,
which is available to authorized users.
* Joana Azeredo
jazeredo@deb.uminho.pt
1 Centre of Biological Engineering, University of Minho, Campus de
Gualtar, Braga 4710-057, Portugal
Appl Microbiol Biotechnol (2016) 100:2141–2151
DOI 10.1007/s00253-015-7247-0
account of their architecture that protects bacteria against ex-
ternal harsh conditions, they constitute an important survival
strategy (Mah and O’Toole 2001; Flemming et al. 2007;
Glonti et al. 2010). Furthermore, biofilms are frequently asso-
ciated as a common source of contamination especially in
healthcare (Reid 1999; Donlan 2001a, b) and food-
processing settings (Brooks and Flint 2008; Shi and Zhu
2009). This happens as a consequence of their inherent toler-
ance to antimicrobial agents due to diffusion limitations,
which can potentially lead to severe persistent infections, par-
ticularly difficult to treat (Costerton et al. 1999; Donlan
2001b; Parsek and Singh 2003; Hall-Stoodley et al. 2004).
In the late 1990s, Hughes et al. partially purified enzymes
capable of degrading bacterial polysaccharides (also known as
depolymerases) from phage solutions (Hughes et al. 1998a).
More recently, several works evidenced that phages can en-
code depolymerases to degrade polymers, either associated
with the cell surface (capsule polysaccharides, e.g., K30 anti-
gens) to facilitate phage adsorption, or EPS involved in bio-
film matrix in order to promote phage diffusion through the
bacterial slime (Glonti et al. 2010; Cornelissen et al. 2011,
2012; Hsu et al. 2013). The depolymerase activity is common-
ly identified by a constantly increasing halo surrounding the
phage plaques (Cornelissen et al. 2011, 2012; Harper et al.
2014), as depicted in Fig. 1. Nonetheless, the formation of
these halo zones is not so clear in some phages encoding
depolymerases, such as the Salmonella phage phi PVP-SE1
that encodes a pectate-lyase in the gene 99 (Santos et al.
2009). It is believed that phages encoding depolymerases
might have a better performance against bacterial biofilms
(Hughes et al. 1998b; Yan et al. 2014). This is not completely
true since there are phages deprived of depolymerases that
have excellent anti-biofilm properties, which is the case of
the Pseudomonas fluorescens phage phiIBB-PF7A
(Sillankorva et al. 2008). Nonetheless, depolymerases may
confer phages a great advantage in biofilm interaction (Lu
and Collins 2007; Cornelissen et al. 2011, 2012).
As the presence and the distribution of depolymerases in
the phage structures is not well understood, here, we report for
the first time a complete study about EPS-degrading enzymes
from all the phages completely sequenced to date.
Overview of phage-encoded depolymerases
The presence of depolymerases in phage genomes may act as
an adjuvant for phage infection, since they degrade polymers
either present in the bacterial surface, such as structural or
capsular polysaccharides, or EPSs present in bacterial biofilms
(Cornelissen et al. 2011; Yan et al. 2014). To get a better
Fig. 1 Activity of phage-
encoded depolymerases. Illustra-
tion of hazy rings (haloes) sur-
rounding the phage plaques of the
Acinetobacter phage vB_AbaP_
CEB1 (unpublished) over time
Fig. 2 Distribution of the
different depolymerase classes
through the structure of tailed
bacteriophages. Levanases,
xylosidades, hyaluronidases,
dextranases, and lipases represent
rare depolymerases domains
found in phages, and therefore,
the location was not possible to
identify. The Bacillus phage
CampHawk represents the only
phage to encode four
depolymerases in different genes
(one sialidase and three pectate
lyases)
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understanding of the diversity, structure, and function of
phage depolymerases, we compiled information about all
depolymerases present in fully sequenced dsDNA phages de-
posited in NCBI (Table S1).
Overall, 160 putative depolymerases were identified in 143
phages (43Myoviridae, 47 Siphoviridae, 37 Podoviridae, and
16 unclassified) that infect 24 genera of bacteria, with lengths
ranging from 197 to 2417 amino acids (Table S1). According
to Drulis-Kawa et al., phage depolymerases appear in two
forms: (i) as integral components of the phage particles or
(ii) as soluble proteins generated during host cell lysis
(Drulis-Kawa et al. 2015). Based on our search, the huge
majority of phage depolymerases (126 proteins) are encoded
in the same open reading frame of phage structural proteins
(mostly on tail fibers, base plates, but sometimes also in the
neck) or in close proximity to those genes (Fig. 2), and were
thus considered as structural proteins (Table S1). Twenty other
depolymerases found in this work might be soluble proteins
since they are distant from any structural gene (Table S1). We
were not able to classify 14 phage depolymerases, and thus,
we considered them as unknown (Table S1).
According to their mode of action, the putative phage
depolymerases were distributed in two main classes: hydro-
lases and lyases, which were further divided into different
subclasses (Table 1). Exolysins (structural lysins) or
endolysins, enzymes that hydrolase the structural LPS and
peptidoglycan encoded by all Caudovirales phages, were al-
ready previously identified and described (Oliveira et al.
2013). Therefore, in this review, we focus on less explored
enzymes that degrade EPS.
Sixteen different domain combinations were found
throughout this analysis, and one representative of each archi-
tecture is depicted in Fig. 3. Although most of domains were
found individually represented in a phage protein, combina-
t ions of domains were also found. For instance,
Pectate_lyase_3 was found alone (Shigella phage Sf6) and
combined with Peptidase_S74 (Bacillus phage CampHawk),
End_tail_spike-Peptidase_S74 complex (Enterobacteria
phage K5), and with Pectin_lyase (Streptomyces phage
phiSASD1).
Most phages encode only one or two depolymerase motifs
in the same gene (Table S1). Nevertheless, some phages can
encode depolymerases in different genes. For example, phage
ϕK1-5 is able to infect and replicate on both K1 and K5
Escherichia coli strains because it encodes two different en-
zymatic tail fiber proteins: an endosialidase that enables the
phage to attach to and degrade K1 polysaccharide capsule,
and a K5 lyase that cleaves the K5 capsular polysaccharides
(Scholl et al. 2001). Another case is the Salmonella enterica
serovar Enteritidis phage Marshall that encodes two tail pro-
teins with beta helix/pectin lyase domains (Luna et al. 2013).
A very interesting and rare example is the Bacillus subtilis
phage CampHawk which encodes a putative peptidase and
three pectate lyase domains in four different tail proteins
(Table S1) (Ritz et al. 2013).
Diversity of phage depolymerases
Hydrolases
O-glycosyl hydrolases (EC 3.2.1.X) are enzymes that catalyze
the hydrolysis of glycosidic bonds (Davies and Henrissat
1995). In this class of enzymes, six different groups of phage
depolymerases were found: sialidases, levanases, xylosidases,
dextranases, rhamnosidases, and peptidases (Table 1).
Sialidases or neuraminidases (EC 3.2.1.18) are a group of
enzymes that hydrolyses the α-linkage of the terminal sialic
acids of various glycans in diverse organisms (Kim et al.
2011b). Sialic acids represent a family of nine-carbon acidic
sugars that are mostly found in the terminal position of oligo-
saccharide chains of glycan molecules present in cell surfaces
(Traving and Schauer 1998; Kim et al. 2011b). Sialic acid
plays an important role on bacterial pathogenesis since path-
ogenic bacteria such as E. coli K1, Haemophilus influenza,
Pasteurella multocida, Neisseria spp., Campylobacter jejuni,
and Streptococcus agalactiae can use this molecule as a
source of nutrients or to increase resistance to host’s immune
defenses by coating themselves in sialic acid (Severi et al.
2007). Nonetheless, it has also been shown that many bacte-
rial species produce sialidases and that their presence has been
associated with increased pathogenesis because they promote
bacterial survival in mucosal niche environments and have
important roles in the interaction with other organisms (Kim
et al. 2011b; Lewis and Lewis 2012). So far, several phages
have been reported to encode endosialidases as part of the tail
structure, which enables the recognition and degradation of
the capsular polysaccharides (Petter and Vimr 1993;
Gerardy-Schahn et al. 1995; Long et al. 1995; Scholl et al.
2001; Scholl and Merril 2005; Schwarzer et al. 2012). Here,
we found sialidase domains in a wide range of phages
targeting different bacterial species. However, the majority
of phages carrying sialidases are specific for Streptococcus
spp. (Table S1). Sialic acid is reported to be one of the most
important carbohydrates for Streptococcus pneumoniae be-
cause it plays a significant role as source of carbon and energy,
receptor of adhesion, and invasion and promotion of biofilm
formation (Gualdi et al. 2012). However, among Gram-
positive bacteria, only S. agalactiae and Streptococcus suis
are reported to produce sialylated polysaccharides in the form
of capsular polysaccharides (Chaffin et al. 2005; Severi et al.
2007). It was already demonstrated that the intraperitoneal
administration of a phage-derived endosialidase in E. coli-in-
fected mice successfully prevented bacteremia and death from
systemic infection (Mushtaq et al. 2004, 2005). Although the
enzyme had no effect on the viability of E. coli cells, the
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degradation of capsular polysaccharides sensitized bacteria to
the bactericidal action of the complement system (Mushtaq et
al. 2004) and also enhanced phagocytosis by macrophages
(Mushtaq et al. 2005).
Levanases (EC 3.2.1.65) are enzymes found in some mi-
croorganisms (e.g., Bacillus and Pseudomonas) that catalyze
the hydrolysis of the β-2,6-linked main chain of levan, a nat-
ural product from the group of fructans (Murakami et al. 1992;
Table 1 Bacteriophage-encoded depolymerases distributed according to their mode of action
Enzyme class EC number Predicted domains found Polymer Bacterium genus
Hydrolases
Sialidases 3.2.1.18 or 3.2.1.129 Sialidases (SUPFAM0050026)
Peptidase_G2 (PF11962)
Peptidase_S74 (PF13884)
End_tail_spike (PF12219)
End_beta_propel (PF12217)
End_N_terminal (PF12218)
Sialic acid Bacillus
Enterobacter
Escherichia
Klebsiella
Prochlorococcus
Pseudomonas
Serratia
Staphylococcus
Streptococcus
Streptomyces
Levanases 3.2.1.65 Glyco_hydro_32N (PF00251)
Glyco_hydro_32C (PF08244)
Levan Bacillus
Xylosidases 3.2.1.37 Glyco_hydro_39 (PF01229) Xylan Caulobacter
Dextranases 3.2.1.11 Glyco_hydro_66 (PF13199) Dextran Lactobacillus
Rhamnosidases 3.2.1.40 Activity detecteda Rhamnogalacturonan Escherichia
Salmonella
Shigella
Peptidases EC 3.4.19.9 DUF867 Poly-γ-glutamate Bacillus
Lyases
Hyaluronidases (EC 4.2.2.1 or EC
4.2.99.1
Hyaluronidase_1 (PF07212) Hyaluronate Streptococcus
Alginate lyases 4.2.2.3 or 4.2.2.11 Activity detectedb Alginate Azotobacter
Pseudomonas
Pectin/pectate lyases 4.2.2.10 or 4.2.2.2 Pec_lyase_C (PF00544)
Pectin lyase-like (SUPFAM)
Pectate_lyase_3 (PF12708)
Galacturonate Bacillus
Brucella
Burkholderia
Cellulophaga
Clostridium
Cronobacter
Enterobacter
Escherichia
Erwinia
Klebsiella
Leuconostoc
Pantoea
Shiegella
Staphylococcus
Streptomyces
Pseudomonas
Rhodococcus
Salmonella
Serratia
Others
Lipases 3.1.1.3. Lipase_GDSL_3 Triacylglycerols Cellulophaga
Pseudomonas
Different enzymes classes are sorted according to the predicted depolymerases domains found and corresponding EC numbers, which act on distinct
polymers. Every bacterial hosts from which depolymerase activity was found in phages is also presented
a Rhamnosidase activity detected in Salmonella phage P22 (Andres et al. 2010), Escherichia phage HK620 (Barbirz et al. 2008), and Shigella phage SF6
(Chua et al. 1999)
b Alginate lyase activity detected in Pseudomonas phage PT-6 (Glonti et al. 2010) and Azotobacter-infecting phage (Davidson et al. 1977)
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Miasnikov 1997). Levan polysaccharide is known to play an
ecological role on Bacillus biofilm formation and mainte-
nance (Marvasi et al. 2010), while on some strains of
Pseudomonas are suggested to be part of a protective capsule
against phages (PATON 1960). Therefore, with no surprise,
the only phage depolymerise domain with levan degradation
(Glyco_hydro_32) activity found belongs to the Bacillus
phage SP10 (Table S1).
Xylosidases (EC 3.2.1.37), dextranases (EC 3.2.1.11),
and rhamnosidases (EC 3.2.1.40) are the classes of en-
zymes representing the rarest depolymerase phage do-
mains (Table S1). These enzymes catalyze the hydroly-
sis of sugars such as xylan (Sunna and Antranikian
1997), dextran (Jiménez 2009), and rhamnogalacturonan
(Yadav et al. 2010), respectively. Such polymers are present in
many bacterial species as described in Table 1. The xylosidase
domain (Glyco_hydro_39) was found in the onlyCaulobacter
phage present in Table S1, while the two dextranase domains
(Glyco_hydro_66) were found in the only Lactobacillus
phage. Although no rhamnosidases domains were found in
our search of phage genomes, rhamnosidase activity was al-
ready reported in Enterobacteria phage P22 (Eriksson et al.
1979), Shigella phage SF6 (Chua et al. 1999), and Escherichia
phage HK620 (Barbirz et al. 2008). The three Podoviridae
phages cleave the respective host cell receptor polysaccharide
by their homotrimeric tailspike proteins (Barbirz et al. 2008).
Furthermore, after being identified, the endorhamnosidase of
phage SF6 was cloned, and its activity was shown by the
cleavage of O-antigen on LPS chain in endorhamnosidase-
treated samples (Chua et al. 1999).
Among hydrolases, there are enzymes that act on peptide
bonds known as peptidases (EC 3.4.X.X). In the present study,
a poly-γ-glutamate (γ-PGA) hydrolase (EC 3.4.19.9)
encoding a peptidase domain DUF867 (PF05908) was found
in four Bacillus phages, namely Bobb, phiAGATE, SPP1, and
phiNIT1. Kimura et al. identified and purified a γ-PGA hy-
drolase from phage phiNIT1 and demonstrated its enzymatic
activity against capsular polypeptides of glutamate with a
gamma-linkage, called poly-γ-glutamate (Kimura and Itoh
2003). This polypeptide is a natural polymer exclusively syn-
thesized by Gram-positive bacteria, including some strains of
Bacillus (Kimura and Itoh 2003; Candela and Fouet 2006).
Lyases
Polysaccharide lyases (EC 4.2.2.X) are a class of enzymes that
cleave (1,4) glycosidic bonds by a β-elimination mechanism
(Sutherland 1995;Michaud et al. 2003). This class of enzymes
comprises three groups of phage depolymerases: hyaluronate,
alginate, and pectin/pectate lyases.
Hyaluronidases or hyaluronate lyases (EC 4.2.2.1 or
4.2.99.1) are a class of enzymes capable of, but not exclusive-
ly, digesting the hyaluronate, a linear unsulfated
glycosaminoglucan polymer found in several organisms, in-
cluding bacteria (Staphylococcus, Clostridium, streptococci
groups A, B, C as well as S. pneumoniae) (Hynes and
Walton 2000). Many extracellular bacterial hyaluronidases
are able to cleave the β-1-4 glycosidic linkage by β-
elimination and are often suggested to be a virulence factor,
by increasing tissue permeability, facilitating the pathogen in-
vasion (Hynes and Walton 2000). The same type of hyaluron-
idases has been found on some prophages from Streptococcus
pyogenes and Streptococcus equi strains (Timoney et al. 1982;
Hynes et al. 1995; Baker et al. 2002; Singh et al. 2014), and
are thought to play a role in phage penetration of streptococcal
hyaluronan capsules, facilitating bacterial lysogenization
Fig. 3 Different phage depolymerase architectures. For the 16 different
architectures, a phage representative was selected. Accession numbers of
phage proteins: (1) YP_003714746, (2) AAL15086, (3) AAQ12204, (4)
AFX93507, (5) AGY47556, (6) CCE60816, (7) AFH14728, (8)
ADA79897, (9) YP_654147, (10) CAJ29458, (11) YP_008242013,
(12) AGO47740, (13) YP_008318429, (14) ACE96035, (15)
AGY46940, and (16) YP_009056510
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(Singh et al. 2014). As no extracellular milieu hyaluronidase
activity was detected, these enzymes were suggested to be part
of the phage particle to degrade the host’s hyaluronic acid
capsules, in order to gain access to their surface where phage
receptors are located. In our search, we have identified two
novel temperate siphoviruses that contain hyaluronidase-
degrading activities, namely the group A streptococcal phage
phiNIH1 and S. equi phage P9.
Alginate lyases are mannuronate (EC 4.2.2.3) or
guluronate lyases (EC 4.2.2.11) that catalyze the degrada-
tion of alginate, a linear polysaccharide of α-L-guluronate
and its C5 epimer β-D-mannuronate (Wong et al. 2000;
Kim et al. 2011a). Alginates are abundant in nature as a
structural component of brown algae (Phaeophyceae)
(Wong et al. 2000; Kim et al. 2011a), and they are also
syn t h e s i z ed by two f am i l i e s o f bac t e r i a , t h e
Pseudomonadaceae (Monday and Schil ler 1996;
Albrecht and Schiller 2005) and the Azotobacteriaceae
(Clementi 1997). Alginate lyases have been isolated from
different sources including marine algae, marine molluscs,
fungi, bacteria, and viruses (Wong et al. 2000), and can be
used to enhance antibiotic killing efficacy against mucoid
bacteria such as P. aeruginosa (Alkawash et al. 2006). To
date, some Azobacter and Pseudomonas spp. phages were
found to encode alginate lyases (Bartell et al. 1966;
Davidson et al. 1977; Glonti et al. 2010), which help
phages to penetrate through the acetylated poly(M)-rich
EPSs produced by their bacterial hosts (Wong et al.
2000; Yan et al. 2014). An example of a phage with
alginate-degrading activity is the P. aeruginosa phage
PT-6 (Glonti et al. 2010). Glonti et al. showed that this
phage was able to reduce the viscosity of four alginate
polymers by 62 to 66 % within 15 min (Glonti et al.
2010).
Pectin or pectate lyases (EC 4.2.2.10 and EC 4.2.2.2)
are pectolytic enzymes that degrade galacturonic acid, a
major constituent of bacterial polysaccharides and plant
cell walls (Frirdich and Whitfield 2005; Garron and
Cygler 2010). Although these enzymes are mainly pro-
duced by plant-associated organisms, they are also com-
monly produced by bacteria (Hugouvieux-Cotte-Pattat et
al. 2014). During this search, we found that the majority
of phage depolymerases belong to the class of pectolytic
enzymes (Table S1). The Pseudomonas putida phages
φ15 and AF, which exhibit biofilm-degrading properties,
encode both pectate lyases on their tailspike genes 17
(Cornelissen et al. 2011) and 19 (Cornelissen et al.
2012), respectively. The EPS-degrading activity of the
tailspikes of phage φ15 was further confirmed after
dropping the recombinant expressed and purified protein
on a bacterial lawn followed by the formation of opaque
halo zones (Cornelissen et al. 2011). However, biofilm
growth was not influenced after addition of UV-
inactivated φ15 phage particles, which are non-infective
but keep the enzymatic activity of their tailspikes
(Cornelissen et al. 2011). The same was observed with
phage AF (Cornelissen et al. 2012). Another example of
phages encoding these enzymes are the Staphylococcus
ep i d e rm id i s phage s vB_Sep iS_ph i I PLA5 and
vB_SepiS_phiIPLA7 (Gutiérrez et al. 2012). The
depolymerase domains, located in the pre-neck appendage
proteins of those phages, are responsible for the good
biofilm-degrading properties of both phages (Gutiérrez et
al. 2012; Melo et al. 2014).
Others
Lipases (EC 3.1.1.3), or triacylglycerol hydrolases, are en-
zymes acting on the carboxyl ester bonds of triacylglycerols
to liberate organic acids and glycerol (Jaeger et al. 1994;
Gupta et al. 2004). Lipases are ubiquitous in nature, and they
are produced by different types of organisms including bacte-
ria. Bacillus, Pseudomonas, and Burkholderia are some of the
most important lipase-producing bacterial genera (Gupta et al.
2004). In this work, only one phage depolymerase domain
with lipids hydrolysis activity (Lipase_GDSL_3) was found
in eight Cellulophaga phages and one Pseudomonas phage
(Table S1).
Potential applications of phage depolymerases
Overall, phages with depolymerase activity have an improved
performance against their target bacteria since these enzymes
help phages in many important processes such as adsorption,
invasion, and disintegration of host bacterial cell as well as
biofilm disruption (Yan et al. 2014).
Phages encoding EPS depolymerases are expected to
be more suitable for phage therapy purposes. In 2002, Tait
el al. reported a complete eradication of Enterobacter
cloacae biofilms after applying a cocktail of three phages
with depolymerase activity (Tait et al. 2002), which re-
vealed the potential of these enzymes to act as adjuvants
for biofilm control. Nonetheless, most of the phages do
not encode such enzymes, and therefore, phages can be
engineered to express depolymerases during phage infec-
tion. For this purpose, Lu and Collins genetically
engineered a T7 phage to express the biofilm-degrading
enzyme dispersin B (Lu and Collins 2007). As a result,
the enzymatic phage was able to efficiently kill biofilm
cells and, at the same time, degrade the biofilm EPS ma-
trix (Lu and Collins 2007).
Although not derived from phages, there are already EPS-
degrading enzymes commercially available such as alginate
lyase (Sigma-Aldrich) and dispersin B (Kane Biotech). This
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suggests that phage-based depolymerases may also have com-
mercial potential.
Furthermore, phage depolymerases can be heterologous
expressed having a wide range of other potential applica-
tions in medical, chemical, or food-processing industry as
suggested in Table 2. Phage depolymerases can also be
used in combination with antibiotics to act as adjuvants.
These enzymes play an important role, for example,
against alginate-producing strains that use alginate as a
barrier to block the diffusion of antibiotics (Bayer et al.
1991; Hatch and Schiller 1998; Abdi-Ali et al. 2006). The
ability of phages to effectively reduce the viscosity of
alginates and EPS produced by P. aeruginosa cells was
already demonstrated (Hanlon et al. 2001), and it was also
shown that the efficacy of antibiotics against mucoid P.
aeruginosa biofilms is enhanced by the administration of
alginate lyase (Alkawash et al. 2006).
Other works have reported the potential of using phage
depolymerases for multiple applications. It was shown that a
capsular depolymerase encoded by a B. subtilis phage im-
proved phagocytic killing of encapsulated Bacillus anthracis
both in vitro (Scorpio et al. 2007) and in vivo (Scorpio et al.
2008). Another work also revealed the potential of a phage
endosialidase to treat systemic infections in mice caused by E.
coli K1 (Mushtaq et al. 2005). The enzyme degraded the cap-
sular polysaccharide of pathogen cells rendering them sensi-
tive to phagocytosis (Mushtaq et al. 2005). It was also shown
that a depolymerase from an Erwinia amylovora phage effec-
tively reduced colonization of fire blight host plants by E.
amylovora (Kim and Geider 2000).
Another application of phage depolymerases is the detec-
tion or diagnosis of bacteria. Lin et al. successfully cloned and
expressed a capsule depolymerase from a K. pneumoniae
phage with specificity for K1 capsule suggesting a potential
tool for the diagnosis of K1 K. pneumoniae infections (Lin et
al. 2014). Furthermore, a work reported by Hsu et al. de-
scribed the characterization of a K. pneumoniae phage
depolymerase with specificity to KN2 capsular polysaccha-
rides which can be successfully used for efficient Klebsiella
capsular typing (Hsu et al. 2013).
Conclusions
The advances in omics and in silico techniques opened the
way to new knowledge about the diversity of phage-encoded
proteins. Phages are natural toolboxes that can offer an arsenal
of proteins with a multitude of potential biotechnological ap-
plications. In this review, we demonstrated that phage ge-
nomes encode a diverse group of enzymes, called
depolymerases, which are used to facilitate early steps of the
phage infection cycle (adsorption and viral DNA injection).
Depolymerases acting on many different substrates (including
sialic acid, levan, xylan, dextran, rhamnogalacturonan,
poly-γ-glutamante, hyaluronate, alginate, and triacylglycerol)
were found in phage genomes, illustrating the complex phage-
host interaction system that was refined during millions of
years. The ability of phage depolymerases to degrade EPS
makes them very attractive for a broad range of applications
especially in clinical and industrial settings.
Table 2 Other biotechnological applications of bacteriophage-encoded depolymerases
Enzyme class Main applications References
Hydrolases
Sialidases Medical industry (processing of clinically relevant asialoproteins) (Kim et al. 2011b)
Levanases Food industry (production of levanoligosaccharides, enzymes
involved in the hydrolysis of polyfructans are of interest for industrial applications)
(Dahech et al. 2013)
Xylanases Chemical industry (biobleaching of wood pulp and in the bioprocessing of textiles)
Food industry (food additives to poultry and in wheat processing)
Processing industry (bioconversion of xylan into higher value added products such as
xylitol)
Bioenergy industry (for more economic biorefining processes)
(Juturu and Wu 2012; Kulkarni
et al. 1999; Beg et al. 2001)
Dextranases Food industry (sugar beet processing) (Jiménez 2009)
Rhamnosidases Food industry (removal of bitterness from citrus fruit juices)
Wine-making (aroma enhancement)
Medical industry (drug preparation)
(Manzanares et al. 2007)
Lyases
Hyaluronidases Medical industry (to increase the effectiveness of local anesthesia in many fields) (Clark and Mellette 1994)
Alginate lyases Preparation of bio-functional alginate oligosaccharides (increase the bifidobacteria flora)
Medical applications (co-administration with antibiotics to treat cystic fibrosis)
Food industry (food additives, stabilizer, and gelling materials)
(Wong et al. 2000; Kim et al.
2011a)
Pectin/pectate
lyases
Food and wine-making industry (fruit juice extraction and clarification (Sieiro et al. 2012)
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